<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01158716</url>
  </required_header>
  <id_info>
    <org_study_id>4.7.7.2010</org_study_id>
    <nct_id>NCT01158716</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning in ad Hoc Percutaneous Coronary Interventions</brief_title>
  <official_title>Remote Ischemic Preconditioning in ad Hoc Percutaneous Coronary Interventions: a Randomized Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiovascular Research Society, Greece</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiovascular Research Society, Greece</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elective percutaneous coronary intervention (PCI) is associated with troponin release in
      approximately one third of cases. Myocardial necrosis may result from downstream embolization
      of atheromatous material, coronary side-branch occlusion and may involve ischemia/reperfusion
      injury. The investigators hypothesized that a single remote ischemic preconditioning cycle
      would reduce peri-procedural troponin release.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Elective percutaneous coronary intervention (PCI) is associated with troponin release in
      approximately one third of cases, which is a sensitive and specific marker of myocyte
      necrosis. Myocardial necrosis may result from downstream embolization of atheromatous
      material, coronary side-branch occlusion and may involve ischemia/reperfusion injury. A
      number of studies have demonstrated that procedure-related troponin release is associated
      with subsequent cardiovascular events and a worst prognosis, especially in those patients
      with the most marked elevation in troponin concentration.

      Recently, 3 cycles of 5-minute ischemia followed by 5-minute reperfusion of the upper
      extremities were shown to reduce troponin release in elective PCI. However, this ischemic
      preconditioning (IPC) protocol requires 30 minutes and is of limited use in the context of
      PCI at the time of initial cardiac catheterization (ad hoc coronary intervention).

      Since experimental evidence suggests that IPC is a graded than an &quot;all-or-nothing&quot;
      phenomenon, and even a short, single IPC cycle may have protective effects in the myocardium,
      the investigators hypothesized that patients undergoing ad hoc coronary intervention would
      have reduced peri-procedural troponin release if subjected to a single, remote IPC cycle,
      between diagnostic catheterization and coronary intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delta Cardiac Troponin I (ΔcTnI)</measure>
    <time_frame>24 hours post PCI</time_frame>
    <description>ΔcTnI is defined as cardiac troponin I (cTnI) at 24 hours post-PCI minus cTnI before coronary angiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chest Pain During Coronary Balloon Occlusion</measure>
    <time_frame>During coronary balloon occlusion</time_frame>
    <description>Chest pain severity was assessed with a 10 point scale (0: no pain, 10: most severe discomfort ever experienced)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECG Evidence of Ischemia During Coronary Balloon Occlusion</measure>
    <time_frame>During coronary balloon occlusion</time_frame>
    <description>ST-segment deviation as monitored during coronary balloon occlusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">94</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Remote Ischemic Preconditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Remote Ischemic Preconditioning</intervention_name>
    <description>Patients are subjected to a 5-minute ischemia of the non-dominant arm with the use of a blood pressure cuff (inflated at 200mm Hg)</description>
    <arm_group_label>Remote Ischemic Preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a significant stenosis as documented in coronary angiography eligible
             for PCI

          -  Patients ≥ 18 of age and able to give informed consent

        Exclusion Criteria:

          -  Severe comorbidity (estimated life expectancy &lt;6 months)

          -  Use of nicorandil or glibenclamide

          -  Elevated baseline cTnI before PCI

          -  Renal disease as documented by serum creatinine before PCI

          -  LVEF&lt;35%
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Demosthenes G Katritsis, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Athens Euroclinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Athens Euroclinic</name>
      <address>
        <city>Athens</city>
        <state>Attica</state>
        <zip>11521</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2010</study_first_submitted>
  <study_first_submitted_qc>July 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2010</study_first_posted>
  <results_first_submitted>March 1, 2014</results_first_submitted>
  <results_first_submitted_qc>March 1, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 9, 2014</results_first_posted>
  <last_update_submitted>March 1, 2014</last_update_submitted>
  <last_update_submitted_qc>March 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiovascular Research Society, Greece</investigator_affiliation>
    <investigator_full_name>Dr D Katritsis</investigator_full_name>
    <investigator_title>Head of Department of Cardiology, Athens Euroclinic</investigator_title>
  </responsible_party>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>remote ischemic preconditioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Remote Ischemic Preconditioning</title>
          <description>Remote Ischemic Preconditioning: Patients are subjected to a 5-minute ischemia of the non-dominant arm with the use of a blood pressure cuff (inflated at 200mm Hg)</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Remote Ischemic Preconditioning</title>
          <description>Remote Ischemic Preconditioning: Patients are subjected to a 5-minute ischemia of the non-dominant arm with the use of a blood pressure cuff (inflated at 200mm Hg)</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="47"/>
            <count group_id="B2" value="47"/>
            <count group_id="B3" value="94"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.8" spread="10.4"/>
                    <measurement group_id="B2" value="60.2" spread="10.9"/>
                    <measurement group_id="B3" value="60.5" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Delta Cardiac Troponin I (ΔcTnI)</title>
        <description>ΔcTnI is defined as cardiac troponin I (cTnI) at 24 hours post-PCI minus cTnI before coronary angiography</description>
        <time_frame>24 hours post PCI</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Remote Ischemic Preconditioning</title>
            <description>Remote Ischemic Preconditioning: Patients are subjected to a 5-minute ischemia of the non-dominant arm with the use of a blood pressure cuff (inflated at 200mm Hg)</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
          </group>
        </group_list>
        <measure>
          <title>Delta Cardiac Troponin I (ΔcTnI)</title>
          <description>ΔcTnI is defined as cardiac troponin I (cTnI) at 24 hours post-PCI minus cTnI before coronary angiography</description>
          <units>ng/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" lower_limit="0.01" upper_limit="0.14"/>
                    <measurement group_id="O2" value="0.19" lower_limit="0.18" upper_limit="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chest Pain During Coronary Balloon Occlusion</title>
        <description>Chest pain severity was assessed with a 10 point scale (0: no pain, 10: most severe discomfort ever experienced)</description>
        <time_frame>During coronary balloon occlusion</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ECG Evidence of Ischemia During Coronary Balloon Occlusion</title>
        <description>ST-segment deviation as monitored during coronary balloon occlusion</description>
        <time_frame>During coronary balloon occlusion</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Remote Ischemic Preconditioning</title>
          <description>Remote Ischemic Preconditioning: Patients are subjected to a 5-minute ischemia of the non-dominant arm with the use of a blood pressure cuff (inflated at 200mm Hg)</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Theodoros Zografos</name_or_title>
      <organization>Cardiovasular RS</organization>
      <phone>+306956161001</phone>
      <email>theodoroszografos@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

